Ftse Mib
33.784,23
0,14%
DAX
17.975,87
0,39%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
0,00%
Bitcoin
59.149,79
0,05%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sarepta Therapeutics Inc New (SRPT) Sarepta Therapeutics Inc New (SRPT) Notizie

Sarepta Therapeutics Inc New

SRPT
131,40
0,77 (0,59%)
Pre Mercato
Ultimo aggiornamento: 13:22:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202422:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
01/5/202400:38BWSarepta Therapeutics Announces Inducement Grants Under..
24/4/202414:30BWSarepta Therapeutics to Announce First Quarter 2024..
29/3/202421:00BWSarepta Therapeutics Announces Inducement Grants Under..
08/3/202423:38EDGAR2Form 144 - Report of proposed sale of securities
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:34EDGAR2Form 144 - Report of proposed sale of securities
04/3/202414:30BWSarepta Therapeutics to Present at Upcoming Investor..
02/3/202401:55EDGAR2Form 144 - Report of proposed sale of securities
02/3/202401:42EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:47EDGAR2Form 144 - Report of proposed sale of securities
01/3/202400:16BWSarepta Therapeutics Announces Inducement Grants Under..
29/2/202415:00BWSarepta Therapeutics Announces Call for Applications for the..
28/2/202422:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
21/2/202414:30BWSarepta Therapeutics to Announce Fourth Quarter and..
16/2/202413:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
13/2/202419:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202400:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202400:29BWSarepta Therapeutics Announces Inducement Grants Under..
29/1/202413:00BWSarepta Therapeutics Announces Positive Data from Part B of..
16/1/202415:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
08/1/202418:08EDGAR2Form 8-K - Current report
08/1/202417:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
02/1/202414:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
30/12/202300:27BWSarepta Therapeutics Announces Inducement Grants Under..
22/12/202314:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
06/12/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202300:34BWSarepta Therapeutics Announces Inducement Grants Under..
21/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202313:30BWSarepta Therapeutics to Present at the UBS Biopharma..
01/11/202321:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
01/11/202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202300:02BWSarepta Therapeutics Announces Inducement Grants Under..
30/10/202322:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..
Apertura: Min: Max:
Chiusura: 130,63

La tua Cronologia

NASDAQ
SRPT
Sarepta Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network